Biopsy Best Practices: Diagnosing Lung LCNEC

Author(s):

Martin Dietrich, MD, PhD,Soo-Ryum Yang, MD

Panelists discuss the factors that influence the decision to perform a fine needle aspirate vs an incisional biopsy, whether testing is conducted in-house or at a central laboratory, and how the results of these tests impact the treatment plan for patients with lung large cell neuroendocrine carcinoma (LCNEC).

EP: 1.Lung Large Cell Neuroendocrine Carcinoma: A Rare but Aggressive Disease Intro

EP: 2.An Overview of the Molecular Characterization of Lung LCNEC

EP: 3.The Pathological Diagnosis of Lung LCNEC

EP: 4.Biomarker Testing Strategies for Lung LCNEC

Now Viewing

EP: 5.Biopsy Best Practices: Diagnosing Lung LCNEC

EP: 6.Lung LCNEC Diagnostic Challenges

EP: 7.A Multidisciplinary Approach to Managing Lung LCNEC

EP: 8.Lung LCNEC Disease Histology and Prognosis

EP: 9.The Role of DLL3 in LCNEC of the Lung

EP: 10.Insights on the LANCE Pilot Study on Lung LCNEC

EP: 11.Novel Targeted Therapies for LCNEC of the Lung

EP: 12.Overview of Studies of BI 764532 for Lung LCNEC

EP: 13.Insights Into Ongoing Investigational Studies in Lung LCNEC

EP: 14.Potential Next-Generation Therapies for Lung LCNEC

What factors determine whether you perform a fine needle aspirate vs incisional biopsy?
- Is your process primarily performed in-house or at a central lab?
How do testing results impact your treatment plan?